Transcatheter Mitral Valve Replacement: A Need for Better Patient Selection.

Competing Interests: Funding Support and Author Disclosures Dr Rodés-Cabau has received institutional research grants from Edwards Lifesciences and Medtronic; and holds the Research Chair ”Fondation Famille Jacques Larivière” for the Development of Structural Heart Disease Interventions. Dr Mack has served as the co-principal investigator or study chair for clinical trials sponsored by Abbott, Edwards Lifesciences, and Medtronic. Dr Regueiro has reported that he has no relationships relevant to the contents of this paper to disclose.